Long Term Clinical Implications in Chinese Patients With Aortic Intramural Hematoma

Completed

• Conditions: Aortic Intramural Hematoma

• Registration Number: NCT03424785
• Lead Sponsor: Shenyang Northern Hospital

Brief Summary

The study evaluates outcomes of intramural hematomas after long-term follow up and establish predictive factors in Chinese population.

Detailed Description

270 intramural hematoma patients with clinical and imaging follow up were retrospectively studied in present study. The primary endpoint was consisted of aortic disease-related death, aortic dissection, penetrating atherosclerotic aortic ulcer , thickening of aorta hematoma and aortic complications requiring surgical or endovascular treatment.

Study Timeline

• Study Start: 2008-06-03
• Primary Completion: 2017-05-14
• Study Completion: 2017-05-14
• Status Verified: 2017-12
• Study First Submitted: 2017-12-11
• Study First Submitted QC: 2018-02-06
• Last Update Submitted: 2018-02-06
• Study First Posted: 2018-02-07
• Last Update Posted: 2018-02-07

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 270

Inclusion Criteria

• Type A aortic hematoma
• Type B aortic hematoma

Exclusion Criteria

• Aortic without initial intimal flap formation.

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
hematoma thickness and a baseline MAD	14years	Medication and short-term imaging are recommended for Chinese IMH patients with a hematoma thickness less than 10.45 mm and a baseline MAD less than 44.75 mm. Rigorous medical observation should also be performed during the acute phase of IMH.